Intermittent caloric restriction

OTHER3 trials

Sponsors

Children's Hospital of Fudan University, Central Hospital, Nancy, France, European Institute of Oncology

Conditions

ATM Gene MutationBRCA MutationCDH1 Gene MutationCHEK2 Gene MutationCardiometabolic RiskCrohn's DiseaseDuctal Carcinoma in SituLobular Carcinoma in Situ

Phase 2

Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion

CompletedNCT06033092

European Institute of OncologyATM Gene Mutation, BRCA Mutation, CDH1 Gene Mutation +6

Start: 2024-06-21End: 2026-07-31Updated: 2026-09-11

Unknown Phase

Effects of Intermittent Caloric Restriction in Youth With Cardiometabolic Risk

CompletedNCT04011995

Children's Hospital of Fudan UniversityCardiometabolic Risk, Obesity, Overweight

Start: 2018-07-12End: 2021-12-01Updated: 2022-03-22

Intermittent Caloric Restriction in Patients With Mild to Moderate Crohn's Disease

RecruitingNCT05683730

Central Hospital, Nancy, FranceCrohn's Disease

Start: 2023-04-18End: 2027-08-01Target: 174Updated: 2023-06-08

Related Papers

A phase II biomarker RCT in women at high risk for breast cancer: Low dose tamoxifen and lifestyle changes for breast cancer prevention (TOLERANT study).

Journal of Clinical Oncology2025-05-28

Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer

PLoS ONE2024-09-033 citations